Bob Flaherty Rides Again! Welcome to our 27th issue of Flaherty Special Situations. This issue we do a job everyone likes to put off: portfolio housecleaning. Our stated goal is to offer stocks we believe can increase 50% to 100% within two years. The old timer's definition of a classic special situation is simple. If your assumptions are correct and you have identified $2 worth of value for each $1 of stock market value, your stock pick should rise regardless of the direction of the stock market.
But everyone makes mistakes, and we do too. Failing to admit them creates a mediocre portfolio. Not every strategic plan goes as expected. The real world intervenes. Also it is easy to fall in love with a product or to become so involved in the struggles of entrepreneurial management to overcome unexpected obstacles that we forget our own mission-to offer our most promising buys to you readers.
I want everyone to enjoy a good 2012. So, let us focus on and stick with our potential winners and advise tax sales for those with broken concepts. We all only have so much time and energy. It is wise to stick with the winners and to concentrate on the most promising prospects if we want a profitable harvest.
All of our recent Flaherty Financial News or Flaherty Special Situation Newsletters have been opened by two to three million online investors and two over 8.2 million. We have an amazing open rate of over 25%. To be reaching millions of new investor readers fills me with gratitude and joy. All the writing effort which goes into turning out each issue would be wasted without readers. To join our financial family and receive our next FREE issues of Flaherty Financial News and also Flaherty Special Situations simply go to our website www.flahertyfinancialnews.com and opt in as a reader. You can opt out any time too.
Look beyond the crowd. Our late friend and guru Sir John Templeton felt the easiest way to prosper was to look out four years when everyone else had to look out only one year. If an institutional player had a bad year, most would be replaced in the casino like atmosphere our stock market has degenerated into. In very feverish times momentum investors get so crazy the long term is lunch. Then even just looking out a little longer than a year is being long run.
Next, estimate or guess what a depressed stock which is selling at a bargain price today might be worth when the weather vane changes from fear to greed or if its situation brightens in the future. Observe what is happening to bring the undervalued stock back into vogue in the future. Improved management, an industry turnaround, new capital, a new product line, an acquisition, the list of catalysts which can improve a company is endless. If the changes could result in a stock price which is 50% to 100% higher, then go for it.
Sir John believed, and I agree, that equities also should be widely diversified because various sections do better or worse each year. So in addition to owning stocks in various countries and no more than 25% in your own country, he felt it was wise to diversify by industry, by company size-micro cap, small cap, middle weight and giant.
Because of the dramatic reduction in independent research, Sir John felt there was greater opportunity in stocks which had little or no independent analyst coverage. Find and buy some good bargains, then as the stock becomes more popular unload at a profit and buy another bargain.
For all companies the most important thing is good management. Check out the track record. Past successes are the most important guide to future success. So the key manager should be experienced, well educated, have good financial backers and a product or service which is unique enough or positioned to generate sizable revenue.
Remember 90% of companies which lose money never become profitable. If you buy a profitable company which has proven it can increase revenues you will avoid 90% of the losers. You will also avoid a company which sounds great but never learns to market and sell and bring home the bacon. A concept company is only an unproven idea until it makes a profit and repeats it. Then it becomes an emerging growth company.
Less is More. Now I could write pages on each of the following past picks I am going to keep as an open BUY right now and the new stock I am going to add to the BUY category. However, that would hurt not help you. We all get flooded with too much information, when a really good special situation can best be summarized in a paragraph or so. If it can't be, worry about whether the concept is too complex to work. In fact, often I find in the many pages about a stock the key facts which are going to drive the stock up if the concept is correct are lost in all the detail or sometimes even missing.
Let us be clear on what I hope each of these picks can do for you. Remember over the long run the average gain for equities is about 9% annually. The ambitious goal of a Flaherty Special Situation is a gain of 50% to 100% over two years. Be patient. It can take time for the events to take place which will lift a stock. Progress must be reported in upcoming quarters so that new investors will see what you saw and become believers too. If a stock reaches the profit target, I suggest you sell. Why? I can think of so many times when my winners became losers when I wanted even more and put off selling too long. Except when we decide a stock is a rare keeper, our game plan is to try and walk away winners when we achieve our profit goals of 50% to 100%.
Our Surviving Buys for 2012 plus one new pick: Apple Computer.
Buy #1: Apple Computer (Nasdaq:AAPL-388.83) nowhas the momentum that IBM and Xerox did at their peak. Its game changing products like upcoming smartphone iPhone 5 are reshaping how the world communicates with each other. Cash plus cash equivalent including investment maturities over 12 months has piled up to over to $76 billion. Security analyst Charlie Wolf expects a spike in iPhone sales and an increase in market share. Looking a year out Apple's projected P/E is slightly over eleven. Needham & Co.'s Wolf (see above) has a target price for the stock of Apple of $540 a share while some analysts are projecting as high as $650.
Buy #2: Mediware Information Systems, Inc. (Nasdaq: MEDW): The U.S. economy may be flat but Mediware is booming, an obvious beneficiary of the billions being spent on improving healthcare like making patient and hospital medical records electronic to improve accuracy, cut costs, eliminate mistakes and, above all, save lives. Back on February 25, 2010 in Flaherty Special Situation #l8 I recommended MEDW at $8.04 and it has taken a nice 81% jump to $14.54. But it is not too late for you to join the party. Led by dynamic CEO Thomas "Kelly" Mann revenues and earnings per share continue to set new records. Mediware is a prime acquisition target in a field which is filled with promise for tomorrow. It should be able to continue to profitably grow until it commands a rich price, perhaps even double its current high. That is because it's Chairman Larry Auriana, who has had that title since l986 and was a director since l983, owns enough shares himself to prevent a hostile takeover from being successful. Mediware was founded in Larry's venture capital days before he co-founded the first of his three Federated Kaufmann Funds but Mediware has a small float so that it is not a holding in any of them.
Financially- shrewd, shareholder-oriented Chairman, experienced solid operating CEO, lots of cash in the bank, a booming business in a growing field favored by government funding. In August 2001 I recommended MEDW for the first time and closed it out with a SELL for a gain of 122%. I think I have a good shot at an encore.
Buy #3: Corcept Therapeutics Inc. (Nasdaq: CORT) Besides a near term orphan drug product for Cushing's Syndrome, CORT is trying to fight the harmful metabolic side effects of morbid obesity, which include heart disease, stroke and Type 2 diabetes from the ingestion of antipsychotic drugs used to stabilize mental illness. Featured in Flaherty Financial Newsletter #28 on Sept 11, 2011 at $2.90, up 18%, CORT's effort is one of the most overlooked and important crusades in modern American medicine. In December 2008 our coverage of CORT began at a price of $0.97 a share, up 202%.
Buy #4: Acadia Healthcare Company Inc. (Nasdaq: ACHC) Bob Flaherty's personal March 23, 2011 Favorites of the Famous pick was PHC, Inc., d/b/a/ Pioneer Behavioral Health Group (NYSEAmex: PHC). PHC, also Flaherty Special Situation #21, was taken over by a private company. The combined company is now trading as Acadia Healthcare Company. The union makes it the largest pure play in in patient behavioral health and pro forma revenues through last June were $325 million. Being larger should make it possible to make bigger acquisitions and substance abuse is still one of America's largest and most neglected problems. Our goal for Acadia remains the same as it was for PHC alone: Hope Treatment! Recovery! A 100% + Profit Opportunity!
Buy #5: Dynavac Technologies (Nasdaq: DVAX) Featured in our Flaherty Special Situation #13 on October 23, 2009 Dynavax stock has now doubled and still appears to be gaining momentum. It accelerated Phase III trial of its Heplisav (liver-saver) vaccine to give results to the FDA early. A recent successful secondary stock offering gives management the muscle to keep heading toward commercial reality. Dynavax's hepatitis B vaccine promises faster more effective life-saving protection with fewer doses and injections. This disease can cause deadly cirrhosis of the liver and cancer. This drug could be a blockbuster. In China alone 120 million people, about 10% of the entire population, are already infected with Hepatitis B and there is a desperate need for an improved vaccination.
Buy #6: BioSante Pharmaceuticals Inc. (Nasdaq: BPAX) The goal of Stephen Simes, CEO of our very first Flaherty Special Situation #1 issued back on December 28, 2007 is still enhancing sexual satisfaction for U.S. women. Men have three such products and it is unfair that women have been so shamefully neglected. Some even use male products which are too strong and inappropriate for them.
BioSante stock once over $10 recently sold about $2.45 up 50% over last year. CEO Simes' ambitious goal: First to market in the U.S. with a product to alleviate Female Sexual Dysfunction. This is a huge $2 billion unmet medical need. Safety testing continues and is going well.
Patience is something most investors lack today. But Simes has so far met every challenge and done as much as anyone could have expected of him. Above all, he has raised the capital in this risk adverse market to keep BioSante going toward the finish line, approval by the FDA of the first U.S. commercial product for women.
Buy #7: OnSecMedical (ONCS.OB) Featured in our Flaherty Special Situation #21 an experienced ambitious team with money raising know how are developing two separate technologies. One is an alternative to cancer surgery which kills cancer cells with less harmful side effects; the other uses DNA to trigger the immune system to fight cancer in spots which are unreachable or currently untreatable. Success would improve many cancer treatment outcomes and save many lives. To flourish management needs to raise $5 million. At a recent price of $0.31 a share ONCS could be a big winner.
Buy #8 MELA Sciences: (Nasdaq: MELA), featured in our Flaherty Special Situation #11 dated August 1, 2009, is backed by legendary venture capitalist Dan Lufkin and is leading a crusade to detect deadly melanoma skin cancer earlier. Its new product MelaFind has been approved by the FDA for use by dermatologists in the U.S. and it has received its CE for use in Europe for crucial early detection of skin cancer to save thousands of lives annually because one American is dying from melanoma an hour. If MELA doesn't make it, it won't be because of lack of good backing.
Buy #9: Samson Oil & Gas Ltd. (NYSEAmex: SSN) Managing Director Terry Barr has given us a nice 85% gain on our pick of last year at $1.24 although the shares of his enterprise can be very volatile. Since he doesn't plan to rest until his stock reaches $10 we would stay on board for the ride. This is a sleeper to watch.
Buy #10 #11 #12 and #13: Harry Barr has four up and comers: Pacific North West Capital (PFN.TO), Fire River Gold (FAV.V), El Nino Ventures (ELN.V), Next Gen Metals Inc. (N.V). Featured in our June 1, 2011 Flaherty Financial News Newsletter #27. With famous mining partners, unlimited energy and a positive attitude a mining entrepreneur uses winning strategies to create hard asset values. When the global economy picks up so will Harry's stocks.
Buy #14: Bard Ventures Ltd. (CBS.V), featured in Flaherty Special Situation #17 February 12, 2010 follows the Templeton idea of buying straw hats in winter and so finding a bargain. Bard has found what it believes is a huge 230 million pound molybdenum resource, which could even be more than doubled. Also recovering demand for moly, which makes steel stronger and more heat resistant, is rising for use in oil pipelines, aircraft, nuclear facilities etc. A possible shortage and a price leap to over $40 a pound by 2014 is projected versus under $14 recently for this volatile metal. Bard's property is not far in British Columbia from existing properties of Thompson Creek Metals (NYSE: TC).
Buy #15: Grizzly Discoveries Ltd (GZD.V) is up 39% but it is too soon to sell. See our Flaherty Special Situation #15 December 15, 2009 and our follow up in our issue of July 2, 2010. In Canada Grizzly is next door-only six kilometers away from where Kinross Gold Corp. has opened a 1.6 million ounce gold mine across the border in the U.S. It's nice to have a wealthy neighbor! And when diamonds are again a girl's best friend, GZD.V will sparkle.
Buy #16: RENN Global Entrepreneurs Fund: (NYSEAmex: RCG) Over the last few years the investor flight from risk has accelerated and with it micro-cap stocks have taken a beating. That means we can find bargains. Now let us turn the negative flight from risk into a positive for us. Most micro-cap and small cap stocks are all depressed and have trouble raising growth capital. When confidence returns, the survivors' stocks will again soar and become overpriced. Yet buying just one right now is risky. Why not buy the portfolio of an entire venture oriented fund, especially one where there is a discount of over 20% between recent price and net asset value? What sells at a discount when investors are driven by fear often commands a premium when they are filled with greed.
The last time I recommended RENN Global Entrepreneurs Fund it consistently went up in price while annual dividends and capital gains reduced our purchase price until we had a gain of over 800%. Then more distributions completely erased our original purchase price and we had a return of infinity, which is what you get when you divide a positive gain by zero.
RCG is managed by my old friend Chairman Russell Cleveland, who is doing his best to sail through this year's choppy waters. But he has a portfolio filled with many undervalued bargains. Russ prefers companies that have achieved revenues and hopefully profits over more risky start- ups when he invests. In venture funds it is often not the number of winners you have but how big your gainers are. In the past some of RCG's gains were positively explosive. For example, we covered Laserscope, which rose from $3 to over $80 where it was acquired in a cash tender offer. When the economy improves, there is no reason to expect RCG shareholders won't get some new fireworks.
Buy #17: Strategic American Oil Corporation (SGCA.OB): Here is our Flaherty Special Situation #20 on SGCA a BUY at $0.20 issued on July 2, 2010 and updated on October 13, 2010. This tiny turnaround is a play on developing America's vast forgotten onshore oil and gas reserves. With promising foothold operations in Texas, Louisiana and Illinois, management is knowledgeable about those local areas. The team should identify and acquire low-risk high-reward domestic oil and gas projects by using modern 3D seismic technology and develop mature projects to their fullest potential and bring hundreds of dead domestic wells backs to life. Many were shut down when the technology did not exist to recover energy economically and the price of oil was dramatically lower. So far SGCA stock has gone down not up but reserves are rising and the best is yet to come.
Buy #18: ITEX Corp. (ITEX.OB) featured in our Flaherty Special Situation #5 continues its 8 year turnaround under the current management. A few ITEX presidents ago, ITEX was booming and the then CEO wanted to grow even faster. So he did a toxic convertible and ITEX not only lost its momentum but almost went under. Under the current management team, ITEX has enjoyed eight consecutive profitable years and is in the best financial condition in its history in spite of this horrible economy. ITEX even pays a dividend. Success should come from developing its wonderful position in the barter business.
Buy #19: South American Gold Corp. (SAGD.OB) Featured in our Flaherty Special Situation #26 in June 8, 2011 this very early stage gold development company is in South West Columbia where FARC guerrilla are still active so it landed a prize property. Now management must raise enough capital to get moving.
Buy #20: ComCam International (CMCJ.OB). Featured in our Flaherty Special Situation #25 management stated it had three major growth opportunities - U.S. Mexico border surveillance, franchising warehouses and stores and in Europe health care in hand anti septic sanitizing for doctors and nurses. So far CMCJ has strengthened its low tech prison monitoring core business and improved its balance sheet. However, management has failed to raise the growth capital to exploit its more significant opportunities and upgrade its technology so its progress has been less than anticipated. Let's give CMCJ another year.
Most of our mistakes had intriguing stories but revenues did not come in as expected. Rather than searching for reasons and asking why, let us admit the original concept was wrong. Let the managements solve their own problems and if revenues or other positives perk up, we can always step in again. But time is money so let us say goodbye. As we prepare for 2012, let us stick with our winners! -RJF
SELL and take tax losses on any other old BUYS. So often we look at companies simply as investments. But most are much more than that. For example those pushing back the boundaries of health care their success or failure involves much more than money-human life.
SELL Universal Gold Mining Corporation: UGDM.OB. Flaherty Special Situation #22 Universal seemed to have everything going for it including the rising price of gold which did soar. This tiny junior miner became a classic case of trying to do too much too soon. It began with an early contrarian gold investment in newly pacified Columbia beside Anglo Gold Ashanti's colossal 12 million ounce gold discovery. Management in Columbia had a super past track record of success, properties with huge potential, top draw backers! Then financiers decided also to go after a property in India to reopen a privatized mine closed when the price of gold was only $300. Alas the key manager in Columbia and the India backers clashed and he withdrew. Necessary financing did not materialize and the key company making opportunity in Columbia had to be sold to Rio Novo Gold (RN.TO) leaving investors with a sigh for what might have been.
SELL Tri-Valley Corp. (NYSEAmex: TIV) featured in our Flaherty Special Situation #10 dated June 8, 2009, has a strategic long-term plan to unlock a bonanza locked up both in its tight sands projects and its prolific upper Vaca Tar Sands project. Because much of the exploration in California's San Joaquin occurred years ago above 12,000 feet but sediments go as deep as 45,000 feet, TIV believes going deep can result in a bonanza. Untapped domestic energy! But TIV has been problem prone and reported figures have been messy. So let us go to the sidelines until TIV is back on track. Long run I think TIV will be O.K.
SELL USCorp. (USCS.OB) featured in Flaherty Special Situation #4 dated June 1, 2008 is a 39 year effort to hit pay dirt by mining executive Bob Dultz with gold properties in Arizona and California. Bob has a never give up attitude. After some setbacks he has relations with a new company to help develop his treasure. Ultimately his persistence should pay off but our two year period has passed.
SELL The Brainy Brands Company (OTCBB: TBBY). Featured in Flaherty Special Situation #24 May 11, 2011 their concept was that a powerful new infomercial would bring in big revenues and profits from parents and grandparents who wanted to give their toddlers a head start. Alas the projected revenue has not come in so far.
SELL PEGG Capital (PGU.DE) This Isle of Man-based venture firm failed to deliver what was expected of it.